{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:00:28Z","timestamp":1753891228564,"version":"3.41.2"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background\/aims<\/jats:title><jats:p>Corneal endothelial cell loss contributes to transplant failure. Autologous plasma products (APP) activate salvaging pathways that can prevent oxidative stress perioperatively. This study aimed to evaluate the safety of intraoperative incubation of full-thickness corneal grafts in platelet-rich plasma (aPRP) and plasma rich in growth factors (PRGF-Endoret) in mitigating postoperative corneal endothelial cell loss (ECL).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Pilot study including patients undergoing penetrating keratoplasty (PK) for various indications between June 2021 and December 2022. Patients were randomly assigned to receive either aPRP or PRGF-Endoret incubation, while those who declined intervention served as the control group. Demographic and clinical data were collected, including preoperative and postoperative endothelial cell count, intraocular pressure, pachymetry, and adverse reactions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirty individuals who underwent PK completed follow-up: eight from the aPRP group, 10 from the PRGF-Endoret group, and 12 from the control group. No adverse events related to APP treatment were recorded. In the first and third postoperative months, the APP group had significantly lower ECL percentages (37% vs. 25%, <jats:italic>p<\/jats:italic>\u2009=\u20090.02, and 44% vs. 33%, <jats:italic>p<\/jats:italic>\u2009=\u20090.02, respectively); this trend was maintained in the sixth month. When stratified, the PRGF-Endoret group showed significant differences in ECL reduction compared to controls at both time points (<jats:italic>p<\/jats:italic>\u2009=\u20090.03 and <jats:italic>p<\/jats:italic>\u2009=\u20090.05, respectively). The aPRP group showed a similar statistically significant outcome exclusively on the third postoperative month (<jats:italic>p<\/jats:italic>\u2009=\u20090.04). APP tended to reduce corneal edema faster than controls. Hexagonality was significantly better in the APP groups in the first and third months, particularly in the PRGF-Endoret group (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.005).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Preoperative incubation with APP is safe and promotes better endothelial cell quality and quantity in the early postoperative period following PK. These findings suggest a potential clinical benefit in enhancing graft outcomes and warrant further investigation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1368117","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T05:00:15Z","timestamp":1723438815000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety of intraoperative autologous plasma incubation of corneal grafts for reducing endothelial cell loss: a pilot study"],"prefix":"10.3389","volume":"11","author":[{"given":"Carolina","family":"Mercado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Lopez-Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borja","family":"De La Sen-Corcuera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Anitua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ignacio","family":"Barraquer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Otero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso L.","family":"Sabater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"volume-title":"Cornea transplantation","year":"2024","author":"Maghsoudlou","key":"ref1"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/ico.0000000000002565","article-title":"Endothelial Keratoplasty update 2020","volume":"40","author":"Price","year":"2021","journal-title":"Cornea"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1136\/bjophthalmol-2020-316705","article-title":"Corneal graft failure: an update","volume":"105","author":"Alio","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/jamaophthalmol.2015.4776","article-title":"Global survey of corneal transplantation and eye banking","volume":"134","author":"Gain","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1001\/jamaophthalmol.2020.3413","article-title":"Association of \u03b1-melanocyte-stimulating hormone with corneal endothelial cell survival during oxidative stress and inflammation-induced cell loss in donor tissue","volume":"138","author":"Lu\u017enik","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.2353\/ajpath.2010.100279","article-title":"Evidence of oxidative stress in the pathogenesis of fuchs endothelial corneal dystrophy","volume":"177","author":"Jurkunas","year":"2010","journal-title":"Am J Pathol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1001\/archopht.126.6.816","article-title":"Corneal endothelial cell damage by free radicals associated with ultrasound oscillation","volume":"126","author":"Murano","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1097\/ICO.0b013e3182a73822","article-title":"Immediate endothelial cell loss after penetrating keratoplasty","volume":"32","author":"Alqudah","year":"2013","journal-title":"Cornea"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/j.1600-0420.2006.00726.x","article-title":"Risk factors for endothelial cell loss post-keratoplasty","volume":"84","author":"Bertelmann","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.51329\/mehdiophthal1424","article-title":"Endothelial cell loss rate after penetrating keratoplasty: optical versus therapeutic grafts","volume":"10","author":"Shams","year":"2021","journal-title":"Med Hypothesis Discov Innov Ophthalmol Summer"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.ophtha.2018.08.002","article-title":"Donor, recipient, and operative factors associated with graft success in the cornea preservation time study","volume":"125","author":"Terry","year":"2018","journal-title":"Ophthalmology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/jamaophthalmol.2018.5669","article-title":"Donor, recipient, and operative factors associated with increased endothelial cell loss in the cornea preservation time study","volume":"137","author":"Lass","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1167\/iovs.02-1255","article-title":"Predicting endothelial cell loss and long-term corneal graft survival","volume":"44","author":"Armitage","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1097\/ico.0000000000003174","article-title":"Survey of Keratoplasty postoperative steroid management","volume":"42","author":"Boychev","year":"2021","journal-title":"Cornea"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000439280","article-title":"Autologous plasma rich in growth factors Eyedrops in refractory cases of ocular surface disorders","volume":"55","author":"Merayo-Lloves","year":"2015","journal-title":"Ophthalmic Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jtos.2022.04.007","article-title":"A multicenter report of the use of plasma rich in growth factors (PRGF) for the treatment of patients with ocular surface diseases in North America","volume":"25","author":"Soifer","year":"2022","journal-title":"Ocul Surf"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/clinpract12010007","article-title":"Plasma rich in growth factors in macular hole surgery","volume":"12","author":"S\u00e1nchez-\u00c1vila","year":"2022","journal-title":"Clin Pract"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40729-016-0052-4","article-title":"Growth factor and pro-inflammatory cytokine contents in platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), advanced platelet-rich fibrin (A-PRF), and concentrated growth factors (CGF)","volume":"2","author":"Masuki","year":"2016","journal-title":"Int J Implant Dent"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/14712598.2021.1945030","article-title":"Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus","volume":"22","author":"Anitua","year":"2022","journal-title":"Expert Opin Biol Ther"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cytogfr.2021.11.003","article-title":"Applications of the regenerative capacity of platelets in modern medicine","volume":"64","author":"Cecerska-Hery\u0107","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"109100","DOI":"10.1016\/j.exer.2022.109100","article-title":"Brief incubation of corneal grafts in activated platelet rich plasma enhances corneal endothelial cell survival and regeneration","volume":"220","author":"Gomez","year":"2022","journal-title":"Exp Eye Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"12176","DOI":"10.3390\/ijms222212176","article-title":"Proteomic characterization of plasma rich in growth factors and undiluted autologous serum","volume":"22","author":"Anitua","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1186\/s13287-020-02046-2","article-title":"Regenerative capacity of the corneal transition zone for endothelial cell therapy","volume":"11","author":"Sie","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1097\/j.jcrs.0000000000000650","article-title":"The corneal endothelium: clinical review of endothelial cell health and function","volume":"47","author":"Gupta","year":"2021","journal-title":"J Cataract Refract Surg"},{"key":"ref25","first-page":"487","article-title":"The use of plasma-rich growth factors (PRGF) in oral surgery","volume":"13","author":"Anitua","year":"2001","journal-title":"Pract Proced Aesthet Dent"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1089\/jop.2019.0119","article-title":"Proliferation of human corneal endothelia in organ culture stimulated by wounding and the engineered human fibroblast growth factor 1 derivative TTHX1114","volume":"36","author":"Eveleth","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3791\/63482","article-title":"A human corneal organ culture model of Descemet's stripping only with accelerated healing stimulated by engineered fibroblast growth factor 1","volume":"185","author":"Pizzuto","year":"2022","journal-title":"J Vis Exp"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/02713683.2023.2173237","article-title":"Beneficial effects of plasma rich in growth factors (PRGF) versus autologous serum and topical insulin in ocular surface cells","volume":"48","author":"Anitua","year":"2023","journal-title":"Curr Eye Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12886-015-0068-1","article-title":"Comparison of corneal endothelial cell measurements by two non-contact specular microscopes","volume":"15","author":"Gasser","year":"2015","journal-title":"BMC Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"517","DOI":"10.4103\/ijo.IJO_574_20","article-title":"Specular microscopy in clinical practice","volume":"69","author":"Chaurasia","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1097\/ico.0000000000002070","article-title":"Treatment of severe Keratoconus Hydrops with Intracameral platelet-rich plasma injection","volume":"38","author":"Alio","year":"2019","journal-title":"Cornea"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1365-2230.2011.04303.x","article-title":"Antibacterial effect of plasma rich in growth factors (PRGF\u00ae-Endoret\u00ae) against Staphylococcus aureus and Staphylococcus epidermidis strains","volume":"37","author":"Anitua","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/cre2.26","article-title":"Basic characteristics of plasma rich in growth factors (PRGF): blood cell components and biological effects","volume":"2","author":"Nishiyama","year":"2016","journal-title":"Clin Exp Dent Res"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"151853","DOI":"10.1016\/j.aanat.2021.151853","article-title":"The inclusion of leukocytes into platelet rich plasma reduces scaffold stability and hinders extracellular matrix remodelling","volume":"240","author":"Anitua","year":"2022","journal-title":"Ann Anat"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s12178-018-9514-z","article-title":"The economics and regulation of PRP in the evolving field of orthopedic biologics","volume":"11","author":"Jones","year":"2018","journal-title":"Curr Rev Musculoskelet Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1368117\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T05:00:18Z","timestamp":1723438818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1368117\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":35,"alternative-id":["10.3389\/fmed.2024.1368117"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1368117","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2024,8,12]]},"article-number":"1368117"}}